Table 3 Percentage of weight loss at the start of treatment and of weight gain/maintenance by the end of treatment, according to tumour location.
Location (n) | % weight loss at the start of the protocol, with respect to normal weight (median, IQR) | % weight gained or maintained at the end of treatment (compared to start of protocol) (median, IQR) | Statistical significance (start of protocol vs. end of chemotherapy) p < 0.005 |
---|---|---|---|
Head-neck (5) | − 16.3 (18.1) | 1.7 (15.6) | 0.080 |
Oesophagus-stomach (13) | − 7.8 (11.5) | − 2.9 (10.6) | 0.101 |
Pancreas-bile ducts (9) | − 7.9 (14.5) | − 5.6 (12.5) | 0.678 |
Colorectal (37) | − 6.1 (9.7) | 0.0 (6.7) | 0.002 |
Gynaecological (32) | − 5.2 (2.2) | 1.7 (3.9) | 0.003 |
Lungs (45) | − 0.6 (15.5) | 0.0 (7.3) | 0.044 |
Other (9) | − 3.8 (7) | 0.0 (16.8) | 0.028 |
Breast (72) | 0.0 (5.8) | 0.0 (4.8) | 0.226 |
Bladder (12) | − 2.0 (5.8) | 1.0 (4.1) | 0.308 |
Total sample (234) | − 3.6% ± 8.2 (mean ± SD) | 0% ± 7.3 (mean ± SD) | < 0.001 |